About this event

  • Date and time Thu 16 Oct 2025 from 8:30am to 17 Oct 2025 at 6:00pm
  • Location Royal Society of Medicine
  • Organised by Pathology, Association for European Cardiovascular Pathology

Join us for our joint meeting with the Association for European Cardiovascular Pathology (AECVP), the only international conference dedicated to cardiovascular pathology. This event brings together leading pathology, cardiology, and related fields experts to discuss the latest advancements in diagnosis, imaging, and innovative therapies for cardiovascular diseases.

Why Attend?

  • Gain insight into cutting-edge diagnostic methods and new therapeutic approaches for cardiovascular disease.
  • Stay updated on recent advances and best practices in managing, caring for, and preventing heart conditions.
  • Explore the expanding field of genetic heart disease and its implications for personalised medicine.
  • Understand current protocols in investigating families affected by sudden cardiac death.
  • Network with international experts, researchers, and clinicians in a multidisciplinary environment.

Key Topics Covered

This year’s theme, Cardiac Pathology at the Frontier of New Therapies, focuses on emerging diagnostic modalities and evolving therapies for genetic and metabolic cardiac diseases. Topics include:

  • Cardiomyopathies and their molecular basis
  • Metabolic cardiac diseases and storage disorders
  • Cardiac amyloidosis and its implications for systemic disease
  • Sudden cardiac death and advances in forensic pathology
  • Cardiac arrhythmias and the role of genetics in risk stratification
  • Endomyocardial biopsy in the diagnosis of cardiac conditions

Highlights

  • High-profile speakers covering topics such as cardiac electrical abnormalities, myocarditis, and genetic cardiomyopathies.
  • Travel grants available for trainees.
  • Awards for the best poster and oral presentations.
  • Learning Objectives

By attending this conference, participants will:

  • Enhance their knowledge of inherited cardiac conditions and their diagnostic challenges.
  • Understand the latest developments in ischaemic heart disease and cardiac transplantation.
  • Gain insights into guidelines for cardiovascular pathology, including the role of general and forensic pathologists.
  • Learn about the importance of endomyocardial biopsy in diagnosing complex cardiac diseases.
  • Foster collaboration within multidisciplinary teams, including consultants, nurses, genetic counsellors, and general practitioners, particularly in cases of sudden cardiac death.

Who Should Attend?

This event is designed for:

  • Pathologists (cardiovascular, general, and forensic)
  • Cardiologists and cardiac surgeons
  • Clinical and research scientists
  • Genetic counsellors and nurses specialising in cardiac care
  • General practitioners with an interest in cardiovascular medicine

Join Us in 2025

With cardiovascular disease remaining the leading cause of morbidity and mortality worldwide, this event is a must-attend for those at the forefront of cardiac pathology. Be part of the discussion that shapes the future of cardiovascular diagnosis and therapy.

More details on registration, abstract submission, and programme schedule will be announced soon.

Follow us on

Facebook 
Instagram
LinkedIn
Twitter 
YouTube

Tickets

Early Bird pricing available until 29 June 2025.

Member

RSM Member
Day 1 Day 2
£150.00 2 Day event - Day 1
£75.00 Gala dinner
£150.00 2 Day event - Day 2
RSM Trainee
Day 1 Day 2
£75.00 2 Day event - Day 1
£75.00 Gala dinner
£75.00 2 Day event - Day 2

Non - Member

Non - Member
Day 1 Day 2
£175.00 2 Day event - Day 1
£75.00 Gala dinner
£175.00 2 Day event - Day 2
AECVP Member
Day 1 Day 2
£150.00 2 Day event - Day 1
£75.00 Gala dinner
£150.00 2 Day event - Day 2
AECVP Trainee
Day 1 Day 2
£75.00 2 Day event - Day 1
£75.00 Gala dinner
£75.00 2 Day event - Day 2
Trainee
Day 1 Day 2
£75.00 2 Day event - Day 1
£75.00 Gala dinner
£75.00 2 Day event - Day 2

Agenda

View the programme 16 October 2025

Registration, tea and coffee
Introduction

Cristina Basso, President, AECVP, Sir Anthony Finkelstein, Vice Chancellor, City St George’s University of London, Mary N. Sheppard, President Pathology Section, Royal Society of Medicine and Steve Cox, Chief Executive, Cardiac Risk in the Young

Sudden death and inherited cardiovascular disorders

Chairs: Pilar Molina, Spain and Samuel Rotman, Switzerland

The normal and obese heart

Joseph Westaby, London

Diagnosis and update on arrhythmogenic cardiomyopathy phenotype

Monica De Gaspari, Italy

Thoracic aortic dissection in the young

Joaquin Lucena, Spain

Classification of inherited cardiomyopathies: Practical guide at autopsy

Mary N. Sheppard, UK

New therapies for cardiomyopathies

Antonis Pantazis, UK

Panel discussion

Poster Session & tea and coffee break

Chairs: Rosa De Gouveia, Portugal and Wouter Van Den Bogaer, Germany

Keynote lecture

Introduced by Mary N. Sheppard, UK

The importance of cardiac pathology, the sudden cardiac death pathway, family screening and genetics. New therapies for cardiomyopathy

Elijah Behr, UK

Lunch

Paediatric, storage and metabolic cardiac disease

Chairs: Heike Goebel, Germany and Dylan Miller, USA

New tools for amyloid diagnosis

Joseph Maleszewski, USA

Diagnosis of metabolic cardiac diseases

Carla Giordano, Italy

Pathology of paediatric cardiac disease causing SCD

Marta Cohen, UK

Childhood cardiomyopathy

Juan Kaski, UK

Panel discussion

Keynote lecture

Introduced by Giulia d’Amati, Italy

Precise diagnosis of cardiac amyloid and treatment

Marianna Fontana, UK

Tea and coffee break

Oral communications

Speaker 1
Speaker 2
Speaker 3
Speaker 4
Speaker 5
Speaker 6
Speaker 7
Speaker 8
Close of day
Drinks reception

For one hour

Gala dinner at RSM

Pre-registered delegates only

View the programme 17 October 2025

Forensic pathology

Chairs: Bela Kubat, The Netherlands and Stephen Cohle, USA

Myocardial injury in forensic setting

Katarzyna Michaud, Switzerland

Drugs, illegal substances, and cardiotoxicity: Morphological changes and pharmacological effects

Christine Jacobsen, Denmark

Vasculitis in forensic practice

Sarah Parsons, Australia

The conduction system: Normal and role in SCD

Ivana Kholova, Finland

Keynote lecture

Introduced by Mary N. Sheppard

Ischemic heart disease and coronary atheroma. My journey

Renu Virmani, USA

Panel discussion

Michal Davies Distinguished Achievement Award lecture

Introduced by Cristina Basso, Italy

My 50+ years with cardiovascular pathology

Ulrik Baandrup, Denmark

Tea and coffee with posters

Transplantation

Chairs: Loukas Kaklamanis, Greece and Marc Halushka, USA

Rejection and vasculopathy in transplant

Annalisa Angelini, Italy

Myocarditis and immune check point inhibitor

James Stone, USA

Cardiac disease and transplantation programme in UK

Stephen Preston

Panel discussion
Lunch

Oral communications

Chairs: John Lomasney, USA and Kristine Olson, Denmark

Speaker 1
Speaker 2
Speaker 3
Speaker 4
Speaker 5
Speaker 6
Speaker 7
Speaker 8
Poster session

Chairs: Jytte Banner, Denmark and Esther Youd, UK

What Is It? Session

Chairs: Patrick Gallagher, UK and Rob Hadden, UK

Speaker 1
Speaker 2
Speaker 3
Speaker 4
Speaker 6
Speaker 7
Speaker 8
Comfort break

Keynote lecture

Introduced by Professor Gillian Leng, President, Royal Society of Medicine

NHS Genomic medicine service: What we learned from the 100K project

Professor Dame Sue Hill, Chief Scientific Officer for England, Responsible Office for Genomics in the NHS

Prize awards
Close of day
AGM

For RSM section members only

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Registration for this event will close at 1:00am on 15 October 2025. Late registrations will not be accepted.

The agenda is subject to change at any time.

If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM’s discretion.

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.